Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Carcinoma and DPYD[original query] |
---|
DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU: results from genotyping study on 75 gastric carcinoma and colon carcinoma patients. Medical oncology (Northwood, London, England) 2007 24 (2): 251-8. Zhang Hong, Li You-ming, Zhang Hao, Jin |
[The association between DPYD gene polymorphism and chemotherapeutic toxicity of 5-FU in gastric carcinoma and colonic carcinoma]. Zhonghua nei ke za zhi 2007 Feb 46 (2): 103-6. Zhang Hong, Li You-ming, Yu Chao-hui, Wang Sheng-qi, Ji Feng, Chen Chun-xi |
Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study. Cancer chemotherapy and pharmacology 2010 Nov 66 (6): 1167-71. Fariña-Sarasqueta Arantza, van Lijnschoten Gesina, Rutten Harm J T, van den Brule Adriaan J |
Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jul 19 (7): 1822-30. Kelemen Linda E, Goodman Marc T, McGuire Valerie, Rossing Mary Anne, Webb Penelope M, , Köbel Martin, Anton-Culver Hoda, Beesley Jonathan, Berchuck Andrew, Brar Sony, Carney Michael E, Chang-Claude Jenny, Chenevix-Trench Georgia, , Cramer Daniel W, Cunningham Julie M, Dicioccio Richard A, Doherty Jennifer A, Easton Douglas F, Fredericksen Zachary S, Fridley Brooke L, Gates Margaret A, Gayther Simon A, Gentry-Maharaj Aleksandra, Høgdall Estrid, Kjaer Susanne Krüger, Lurie Galina, Menon Usha, Moorman Patricia G, Moysich Kirsten, Ness Roberta B, Palmieri Rachel T, Pearce Celeste L, Pharoah Paul D P, Ramus Susan J, Song Honglin, Stram Daniel O, Tworoger Shelley S, Van Den Berg David, Vierkant Robert A, Wang-Gohrke Shan, Whittemore Alice S, Wilkens Lynne R, Wu Anna H, Schildkraut Joellen M, Sellers Thomas A, Goode Ellen L, |
Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma. Anti-cancer drugs 2013 Jul 24 (6): 617-22. Fushiya Nao, Takagi Ichiro, Nishino Hirokazu, Akizuki Setsuko, Ohnishi Akihi |
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular nutrition & food research 2014 Oct 58 (10): 2023-35. Kelemen Linda E, Terry Kathryn L, Goodman Marc T, Webb Penelope M, Bandera Elisa V, McGuire Valerie, Rossing Mary Anne, Wang Qinggang, Dicks Ed, Tyrer Jonathan P, Song Honglin, Kupryjanczyk Jolanta, Dansonka-Mieszkowska Agnieszka, Plisiecka-Halasa Joanna, Timorek Agnieszka, Menon Usha, Gentry-Maharaj Aleksandra, Gayther Simon A, Ramus Susan J, Narod Steven A, Risch Harvey A, McLaughlin John R, Siddiqui Nadeem, Glasspool Rosalind, Paul James, Carty Karen, Gronwald Jacek, Lubi?ski Jan, Jakubowska Anna, Cybulski Cezary, Kiemeney Lambertus A, Massuger Leon F A G, van Altena Anne M, Aben Katja K H, Olson Sara H, Orlow Irene, Cramer Daniel W, Levine Douglas A, Bisogna Maria, Giles Graham G, Southey Melissa C, Bruinsma Fiona, Kjaer Susanne K, Høgdall Estrid, Jensen Allan, Høgdall Claus K, Lundvall Lene, Engelholm Svend-Aage, Heitz Florian, du Bois Andreas, Harter Philipp, Schwaab Ira, Butzow Ralf, Nevanlinna Heli, Pelttari Liisa M, Leminen Arto, Thompson Pamela J, Lurie Galina, Wilkens Lynne R, Lambrechts Diether, Van Nieuwenhuysen Els, Lambrechts Sandrina, Vergote Ignace, Beesley Jonathan, , Fasching Peter A, Beckmann Matthias W, Hein Alexander, Ekici Arif B, Doherty Jennifer A, Wu Anna H, Pearce Celeste L, Pike Malcolm C, Stram Daniel, Chang-Claude Jenny, Rudolph Anja, Dörk Thilo, Dürst Matthias, Hillemanns Peter, Runnebaum Ingo B, Bogdanova Natalia, Antonenkova Natalia, Odunsi Kunle, Edwards Robert P, Kelley Joseph L, Modugno Francesmary, Ness Roberta B, Karlan Beth Y, Walsh Christine, Lester Jenny, Orsulic Sandra, Fridley Brooke L, Vierkant Robert A, Cunningham Julie M, Wu Xifeng, Lu Karen, Liang Dong, Hildebrandt Michelle A T, Weber Rachel Palmieri, Iversen Edwin S, Tworoger Shelley S, Poole Elizabeth M, Salvesen Helga B, Krakstad Camilla, Bjorge Line, Tangen Ingvild L, Pejovic Tanja, Bean Yukie, Kellar Melissa, Wentzensen Nicolas, Brinton Louise A, Lissowska Jolanta, Garcia-Closas Montserrat, Campbell Ian G, Eccles Diana, Whittemore Alice S, Sieh Weiva, Rothstein Joseph H, Anton-Culver Hoda, Ziogas Argyrios, Phelan Catherine M, Moysich Kirsten B, Goode Ellen L, Schildkraut Joellen M, Berchuck Andrew, Pharoah Paul D P, Sellers Thomas A, Brooks-Wilson Angela, Cook Linda S, Le Nhu |
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS. Gut 2015 Jan 64 (1): 111-20. Rosmarin Dan, Palles Claire, Pagnamenta Alistair, Kaur Kulvinder, Pita Guillermo, Martin Miguel, Domingo Enric, Jones Angela, Howarth Kimberley, Freeman-Mills Luke, Johnstone Elaine, Wang Haitao, Love Sharon, Scudder Claire, Julier Patrick, Fernández-Rozadilla Ceres, Ruiz-Ponte Clara, Carracedo Angel, Castellvi-Bel Sergi, Castells Antoni, Gonzalez-Neira Anna, Taylor Jenny, Kerr Rachel, Kerr David, Tomlinson I |
Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History. OncoTargets and therapy 2020 13 8795-8802. He Wenwu, Leng Xuefeng, Yang Yanyu, Peng Lin, Shao Yang, Li Xue, Han Yongt |
Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. Surgical oncology 2020 Sep 35 388-398. Puerta-García E, Urbano-Pérez D, Carrasco-Campos M I, Pérez-Ramírez C, Segura-Pérez A, Calleja-Hernández , Cañadas-Garre |
Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma-Carcinoma Pathway Progression. Journal of inflammation research 2021 11 14 5403-5417. Zhang Yu, Zhang Xin, Jin Zhuoyi, Chen Huiyan, Zhang Chenjing, Wang Wangyue, Jing Jiyong, Pan Wenshe |
Upfront DPYD Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress. Current oncology (Toronto, Ont.) 2022 2 29 (2): 497-509. Desilets Antoine, McCarvill William, Aubin Francine, Bahig Houda, Ballivy Olivier, Charpentier Danielle, Filion Édith, Jamal Rahima, Lambert Louise, Nguyen-Tan Phuc Felix, Vadnais Charles, Weng Xiaoduan, Soulières Den |
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes. Scientific reports 2022 10 12 (1): 17928. Ohnami Sumiko, Naruoka Akane, Isaka Mitsuhiro, Mizuguchi Maki, Nakatani Sou, Kamada Fukumi, Shimoda Yuji, Sakai Ai, Ohshima Keiichi, Hatakeyama Keiichi, Maruyama Kouji, Ohde Yasuhisa, Kenmotsu Hirotsugu, Takahashi Toshiaki, Akiyama Yasuto, Nagashima Takeshi, Urakami Kenichi, Ohnami Shumpei, Yamaguchi K |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: